Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 53 articles: HTML format

Single Articles

September 2024
1. CHEN C, Han J, He Q, Yao Q, et al
   Tumor-infiltrating immune cell profiles and changes associate with additional trastuzumab in preoperative chemotherapy for patients with HER2-positive gastric cancer.
   Br J Cancer. 2024 Sep 23. doi: 10.1038/s41416-024-02835.
   PubMed     Abstract available
   
   
   
2. KANDA M, Kasahara Y, Shimizu D, Shinozuka T, et al
   Dual-modified antisense oligonucleotides targeting oncogenic protocadherin to treat gastric cancer.
   Br J Cancer. 2024 Sep 20. doi: 10.1038/s41416-024-02859.
   PubMed     Abstract available
   
   
   August 2024
3. GU Y, Sun M, Fang H, Shao F, et al
   Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer.
   Br J Cancer. 2024 Aug 31. doi: 10.1038/s41416-024-02825.
   PubMed     Abstract available
   
   
   July 2024
4. FANG M, Lin Y, Xue C, Sheng K, et al
   The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis.
   Br J Cancer. 2024 Jul 13. doi: 10.1038/s41416-024-02778.
   PubMed     Abstract available
   
   
   
5. HARA Y, Baba Y, Oda E, Harada K, et al
   Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.
   Br J Cancer. 2024 Jul 12. doi: 10.1038/s41416-024-02753.
   PubMed     Abstract available
   
   
   
6. ANGERILLI V, Sabella G, Simbolo M, Lagano V, et al
   Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms.
   Br J Cancer. 2024;131:159-170.
   PubMed     Abstract available
   
   
   June 2024
7. LI X, Xie G, Chen J, Wang Y, et al
   Tumour cell-derived serglycin promotes IL-8 secretion of CAFs in gastric cancer.
   Br J Cancer. 2024 Jun 11. doi: 10.1038/s41416-024-02735.
   PubMed     Abstract available
   
   
   May 2024
8. MURPHY JD, Gadalla SM, Anderson LA, Rabkin CS, et al
   Autoimmune conditions and gastric cancer risk in a population-based study in the United Kingdom.
   Br J Cancer. 2024 May 22. doi: 10.1038/s41416-024-02714.
   PubMed     Abstract available
   
   
   March 2024
9. SUH YS, Lee J, George J, Seol D, et al
   RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation.
   Br J Cancer. 2024 Mar 11. doi: 10.1038/s41416-024-02642.
   PubMed     Abstract available
   
   
   February 2024
10. SAITO T, Kurokawa Y, Fujitani K, Kawabata R, et al
    Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
    Br J Cancer. 2024 Feb 7. doi: 10.1038/s41416-023-02540.
    PubMed     Abstract available
    
    
    
11. CECCHINI M, Cleary JM, Shyr Y, Chao J, et al
    NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2024;130:476-482.
    PubMed     Abstract available
    
    
    
12. GROSSER B, Emmerson J, Reitsam NG, Cunningham D, et al
    Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
    Br J Cancer. 2024;130:457-466.
    PubMed     Abstract available
    
    
    January 2024
13. WANG J, Sun N, Kunzke T, Shen J, et al
    Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.
    Br J Cancer. 2024 Jan 24. doi: 10.1038/s41416-023-02559.
    PubMed     Abstract available
    
    
    
14. CAI F, Yang X, Ma G, Wang P, et al
    EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-kappaB signalling activation independent of hydroxylase activity.
    Br J Cancer. 2024 Jan 6. doi: 10.1038/s41416-023-02546.
    PubMed     Abstract available
    
    
    December 2023
15. KAMIYA H, Komatsu S, Takashima Y, Ishida R, et al
    Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
    Br J Cancer. 2023 Dec 26. doi: 10.1038/s41416-023-02532.
    PubMed     Abstract available
    
    
    November 2023
16. ALLAN Z, Witts S, Tie J, Tebbutt N, et al
    The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
    Br J Cancer. 2023;129:1717-1726.
    PubMed     Abstract available
    
    
    August 2023
17. CHEN T, Li D, Wang Y, Shen X, et al
    Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1alpha-FBLN5 signaling pathway.
    Br J Cancer. 2023 Aug 29. doi: 10.1038/s41416-023-02409.
    PubMed     Abstract available
    
    
    
18. ANDO K, Nakamura Y, Kitao H, Shimokawa M, et al
    Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
    Br J Cancer. 2023 Aug 2. doi: 10.1038/s41416-023-02378.
    PubMed     Abstract available
    
    
    July 2023
19. LIU X, Lv K, Wang J, Lin C, et al
    C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02336.
    PubMed     Abstract available
    
    
    
20. LEE JE, Kim KT, Shin SJ, Cheong JH, et al
    Genomic and evolutionary characteristics of metastatic gastric cancer by routes.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02338.
    PubMed     Abstract available
    
    
    June 2023
21. DONG X, Fan J, Xie W, Wu X, et al
    Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.
    Br J Cancer. 2023 Jun 29. doi: 10.1038/s41416-023-02319.
    PubMed     Abstract available
    
    
    April 2023
22. LIU DHW, Kim YW, Sefcovicova N, Laye JP, et al
    Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
    Br J Cancer. 2023 Apr 7. doi: 10.1038/s41416-023-02257.
    PubMed     Abstract available
    
    
    
23. LAAKSONEN MA, Li S, Canfell K, MacInnis RJ, et al
    The future burden of oesophageal and stomach cancers attributable to modifiable behaviours in Australia: a pooled cohort study.
    Br J Cancer. 2023;128:1052-1069.
    PubMed     Abstract available
    
    
    February 2023
24. STARLING N, Cunningham D
    Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhonen, T Kuitunen, P Nyandoto & M Kouri.
    Br J Cancer. 2023 Feb 16. doi: 10.1038/s41416-023-02146.
    PubMed     Abstract available
    
    
    January 2023
25. NI T, Chu Z, Tao L, Zhao Y, et al
    PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.
    Br J Cancer. 2023 Jan 12. doi: 10.1038/s41416-022-02118.
    PubMed     Abstract available
    
    
    
26. OKUNO K, Watanabe S, Roy S, Kanda M, et al
    A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Br J Cancer. 2023 Jan 11. doi: 10.1038/s41416-022-02138.
    PubMed     Abstract available
    
    
    November 2022
27. KOCK AM BRINK M, Dunst LS, Behrens HM, Kruger S, et al
    Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma.
    Br J Cancer. 2022 Nov 8. pii: 10.1038/s41416-022-02047.
    PubMed     Abstract available
    
    
    August 2022
28. YU K, Gu Y, Zhang P, Fang H, et al
    Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer.
    Br J Cancer. 2022 Aug 24. pii: 10.1038/s41416-022-01939.
    PubMed     Abstract available
    
    
    
29. CUI K, Yao S, Liu B, Sun S, et al
    A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer.
    Br J Cancer. 2022 Aug 8. pii: 10.1038/s41416-022-01936.
    PubMed     Abstract available
    
    
    June 2022
30. RABBANI S, Santoni G, Lagergren J, Xie SH, et al
    Use of anti-androgenic 5alpha-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01872.
    PubMed     Abstract available
    
    
    May 2022
31. YAO X, He Z, Qin C, Zhang P, et al
    Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01834.
    PubMed     Abstract available
    
    
    
32. ZANG WJ, Hu YL, Qian CY, Feng Y, et al
    HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01805.
    PubMed     Abstract available
    
    
    
33. ALICANDRO G, Bertuccio P, Collatuzzo G, Pelucchi C, et al
    The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 May 27. pii: 10.1038/s41416-022-01857.
    PubMed     Abstract available
    
    
    
34. MARTIMIANAKI G, Alicandro G, Pelucchi C, Bonzi R, et al
    Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium.
    Br J Cancer. 2022 May 24. pii: 10.1038/s41416-022-01856.
    PubMed     Abstract available
    
    
    February 2022
35. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Correction: Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01761.
    PubMed    
    
    
    
36. DALMARTELLO M, Turati F, Zhang ZF, Lunet N, et al
    Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01750.
    PubMed     Abstract available
    
    
    
37. LI Y, Liu C, Zhang X, Huang X, et al
    CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/beta-catenin signalling pathway.
    Br J Cancer. 2022 Feb 22. pii: 10.1038/s41416-022-01747.
    PubMed     Abstract available
    
    
    January 2022
38. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Jan 13. pii: 10.1038/s41416-021-01693.
    PubMed     Abstract available
    
    
    December 2021
39. ADIB E, El Zarif T, Nassar AH, Akl EW, et al
    CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Br J Cancer. 2021 Dec 23. pii: 10.1038/s41416-021-01673.
    PubMed     Abstract available
    
    
    November 2021
40. CHEN K, Gu Y, Cao Y, Fang H, et al
    TIM3(+) cells in gastric cancer: clinical correlates and association with immune context.
    Br J Cancer. 2021 Nov 1. pii: 10.1038/s41416-021-01607.
    PubMed     Abstract available
    
    
    October 2021
41. SHIMURA T, Kandimalla R, Okugawa Y, Ohi M, et al
    Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer.
    Br J Cancer. 2021 Oct 21. pii: 10.1038/s41416-021-01581.
    PubMed     Abstract available
    
    
    
42. KOHLRUSS M, Krenauer M, Grosser B, Pfarr N, et al
    Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01587.
    PubMed     Abstract available
    
    
    
43. BAXTER MA, Middleton F, Cagney HP, Petty RD, et al
    Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.
    Br J Cancer. 2021;125:1068-1079.
    PubMed     Abstract available
    
    
    July 2021
44. ZHENG J, Santoni G, Xie SH, Lagergren J, et al
    Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
    Br J Cancer. 2021;125:277-283.
    PubMed     Abstract available
    
    
    June 2021
45. LEE IS, Ahn J, Kim K, Okugawa Y, et al
    A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Br J Cancer. 2021 Jun 23. pii: 10.1038/s41416-021-01461.
    PubMed     Abstract available
    
    
    April 2021
46. TANAKA H, Kanda M, Miwa T, Umeda S, et al
    G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01366.
    PubMed     Abstract available
    
    
    March 2021
47. TAKASHIMA T, Taniyama D, Sakamoto N, Yasumoto M, et al
    Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
    Br J Cancer. 2021 Mar 30. pii: 10.1038/s41416-021-01364.
    PubMed     Abstract available
    
    
    
48. LI Z, Wu X, Gao X, Shan F, et al
    Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma.
    Br J Cancer. 2021;124:942-950.
    PubMed     Abstract available
    
    
    February 2021
49. MIWA T, Kanda M, Shimizu D, Umeda S, et al
    Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
    Br J Cancer. 2021 Feb 3. pii: 10.1038/s41416-021-01271.
    PubMed     Abstract available
    
    
    October 2020
50. SAITO R, Shoda K, Maruyama S, Yamamoto A, et al
    Platelets enhance malignant behaviours of gastric cancer cells via direct contacts.
    Br J Cancer. 2020 Oct 28. pii: 10.1038/s41416-020-01134.
    PubMed     Abstract available
    
    
    
51. YAMASHITA K, Iwatsuki M, Yasuda-Yoshihara N, Morinaga T, et al
    Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
    Br J Cancer. 2020 Oct 26. pii: 10.1038/s41416-020-01138.
    PubMed     Abstract available
    
    
    
52. OPENSHAW MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, et al
    Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
    Br J Cancer. 2020;123:1271-1279.
    PubMed     Abstract available
    
    
    September 2020
53. ZHAO J, Fu X, Chen H, Min L, et al
    G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.
    Br J Cancer. 2020 Sep 29. pii: 10.1038/s41416-020-01067.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.